10 newer rulings cite the same tariff codes.
Classification can shift over time. Review the more recent rulings below before relying on this one.
The tariff classification of Allopurinol (CAS-315-30-0) imported in dosage/tablet form, from India
Issued February 28, 2008 by U.S. Customs and Border Protection.
Cite this ruling
Copies to clipboardN0 N023649 (February 28, 2008)
Tariff classification
HTS codes: 3004.90.9190
Headings: 3004
Product description
Allopurinol in dosage form is a medicinal preparation containing Allopurinol, a drug indicated for the treatment hyperuricemia in patients with gout, as the active ingredient.
CBP rationale
The applicable subheading for Allopurinol, imported in dosage form, will be 3004.90.9190, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.
Full text
N023649 February 28, 2008 CLA-2-30:OT:RR:E:NC:2:238 CATEGORY: Classification TARIFF NO.: 3004.90.9190 Mr. Colm F. Moynihan NorthStar Healthcare Limited 3300 Cork Airport Business Park Kinsale Road Cork, Ireland RE: The tariff classification of Allopurinol (CAS-315-30-0) imported in dosage/tablet form, from India Dear Mr. Moynihan: In your letter dated February 22, 2008, you requested a tariff classification ruling. Allopurinol in dosage form is a medicinal preparation containing Allopurinol, a drug indicated for the treatment hyperuricemia in patients with gout, as the active ingredient. The applicable subheading for Allopurinol, imported in dosage form, will be 3004.90.9190, Harmonized Tariff Schedule of the United States (HTSUS), which provides for “Medicaments … consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses … or in forms or packings for retail sale: Other: Other: Other: Other.” The rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This merchandise may be subject to the Federal Food, Drug, and Cosmetic Act and/or The Public Health Security and Bioterrorism Preparedness and Response Act of 2002 (The Bioterrorism Act), which are administered by the U.S. Food and Drug Administration (FDA). Information on the Federal Food, Drug, and Cosmetic Act, as well as The Bioterrorism Act, can be obtained by calling the FDA at 1-888-463-6332, or by visiting their website at www.fda.gov. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Metformin Hydrochloride Extended Release Tablets in dosage form, from India
The tariff classification of Sodium Phenylacetate and Sodium Benzoate injection vials in dosage form, from India
The tariff classification, country of origin and country of origin marking of the AUGMENT® Bone Graft Kit from the United Kingdom and the applicability of subheading 9801.00.10, HTSUS
The tariff classification of GRASTEK® and RAGWITEK® sublingual tablets in dosage form, from Denmark
The tariff classification of Glyburide Tablets and Glyburide-Metformin Hydrochloride Tablets in dosage form, from India
The tariff classification of Voriconazole Tablets and Nateglinide Tablets in dosage form, from Malta and India, respectively
The tariff classification of Zolderonic Acid Injection in dosage form, from India
The tariff classification of Zoledronic Acid Injections in dosage form, from Austria
The tariff classification, country of origin marking of KANUMA™ (sebelipase alfa) in dosage form and the applicability of subheading 9801.00.10, HTSUS
The tariff classification of Etomidate Injection, USP and Glipizide Extended Release Tablets, in dosage form, from India
Follow N023649
Get an email if this ruling is revoked or modified, or a newer ruling supersedes it.
One email per day at most. Confirm your address once, unsubscribe anytime.
Searching CBP rulings the smart way
Rulings are precedent. See which ones apply to your product: TariffLens semantically searches all 200,000+ CBP rulings and builds defensible classifications backed by ruling citations.